193 related articles for article (PubMed ID: 32706625)
21. Regulated LC-MS/MS bioanalysis technology for therapeutic antibodies and Fc-fusion proteins using structure-indicated approach.
Iwamoto N; Shimada T
Drug Metab Pharmacokinet; 2019 Feb; 34(1):19-24. PubMed ID: 30392772
[TBL] [Abstract][Full Text] [Related]
22. Bioanalytical approaches to analyzing peptides and proteins by LC--MS/MS.
Ewles M; Goodwin L
Bioanalysis; 2011 Jun; 3(12):1379-97. PubMed ID: 21679032
[TBL] [Abstract][Full Text] [Related]
23. Liquid chromatography coupled with tandem mass spectrometry for the bioanalysis of proteins in drug development: practical considerations in assay development and validation.
Liu G; Ji QC; Dodge R; Sun H; Shuster D; Zhao Q; Arnold M
J Chromatogr A; 2013 Apr; 1284():155-62. PubMed ID: 23466204
[TBL] [Abstract][Full Text] [Related]
24. Reliable procedures to evaluate and repair crosstalk for bioanalytical MS/MS assays.
Morin LP; Mess JN; Furtado M; Garofolo F
Bioanalysis; 2011 Feb; 3(3):275-83. PubMed ID: 21320048
[TBL] [Abstract][Full Text] [Related]
25. How much separation for LC-MS/MS quantitative bioanalysis of drugs and metabolites?
Tan A; Fanaras JC
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1084():23-35. PubMed ID: 29558737
[TBL] [Abstract][Full Text] [Related]
26. 2020 White Paper on Recent Issues in Bioanalysis: BMV of Hybrid Assays, Acoustic MS, HRMS, Data Integrity, Endogenous Compounds, Microsampling and Microbiome (
Neubert H; Alley SC; Lee A; Jian W; Buonarati M; Edmison A; Garofolo F; Gorovits B; Haidar S; Mylott B; Nouri P; Qian M; Vinter S; Voelker T; Welink J; Wu J; Yang E; Yu H; Evans C; Summerfield S; Wang J; Bateman K; Boer J; Dean B; Dillen L; Faustino P; Ferrari L; Hughes N; Luo L; Olah T; Post N; Spellman DS; Sydor J; Zhang H; Zhang J; Zhang J; Fandozzi C; Wilson A; Fraier D; Beaver CJ; Dandamudi S; Dasgupta A; Elliott R; Ji A; Li W; McGuinness M; Lima Santos GM; Mirza T; Savoie N; Shakleya D; Sporring S; Stojdl S; Sundman P; Tampal N; Woolf E
Bioanalysis; 2021 Feb; 13(4):203-238. PubMed ID: 33470871
[TBL] [Abstract][Full Text] [Related]
27. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
de Dios K; Manibusan A; Marsden R; Pinkstaff J
J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
[TBL] [Abstract][Full Text] [Related]
28. Managing scientific, technical and regulatory innovation in regulated bioanalysis: a discussion paper from the European Bioanalysis Forum.
Timmerman P; Henderson N; Smeraglia J; Mulder H; Ingelse B; Brudny-Kloeppel M; Companjen A
Bioanalysis; 2013 Jan; 5(2):139-45. PubMed ID: 23330557
[TBL] [Abstract][Full Text] [Related]
29. LC-MS-based quantification of intact proteins: perspective for clinical and bioanalytical applications.
van den Broek I; van Dongen WD
Bioanalysis; 2015; 7(15):1943-58. PubMed ID: 26295992
[TBL] [Abstract][Full Text] [Related]
30. Bioanalytical method development and validation: Critical concepts and strategies.
Moein MM; El Beqqali A; Abdel-Rehim M
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1043():3-11. PubMed ID: 27720355
[TBL] [Abstract][Full Text] [Related]
31. Supported liquid extraction versus liquid-liquid extraction for sample preparation in LC-MS/MS-based bioanalysis.
Zhang Y; Cao H; Jiang H
Bioanalysis; 2013 Feb; 5(3):285-8. PubMed ID: 23394695
[No Abstract] [Full Text] [Related]
32. A simplified and completely automated workflow for regulated LC-MS/MS bioanalysis using cap-piercing direct sampling and evaporation-free solid phase extraction.
Zheng N; Buzescu A; Pasas-Farmer S; Arnold ME; Ouyang Z; Jemal M; Peng Q; Van Vleet T; Zeng J
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 921-922():64-74. PubMed ID: 23435343
[TBL] [Abstract][Full Text] [Related]
33. Microflow LC-MS/MS to improve sensitivity for antisense oligonucleotides bioanalysis: critical role of sample cleanness.
Jiang D; Yuan L
Bioanalysis; 2022 Nov; 14(21):1365-1376. PubMed ID: 36625771
[No Abstract] [Full Text] [Related]
34. Antibody-drug conjugate bioanalysis using LB-LC-MS/MS hybrid assays: strategies, methodology and correlation to ligand-binding assays.
Wang J; Gu H; Liu A; Kozhich A; Rangan V; Myler H; Luo L; Wong R; Sun H; Wang B; Vezina HE; Deshpande S; Zhang Y; Yang Z; Olah TV; Aubry AF; Arnold ME; Pillutla R; DeSilva B
Bioanalysis; 2016 Jul; 8(13):1383-401. PubMed ID: 27277879
[TBL] [Abstract][Full Text] [Related]
35. 'Large Meets Small': connecting the bioanalytical community around peptide and protein bioanalysis with LC-MS(/MS).
Timmerman P; Lausecker B; Barosso B; van Amsterdam P; Luedtke S; Dijksman J
Bioanalysis; 2012 Mar; 4(6):627-31. PubMed ID: 22452251
[TBL] [Abstract][Full Text] [Related]
36. Hybrid LC-MS as a powerful tool for supporting protein bioanalysis in gene and cell therapies.
Wei D; Kim Y; Sugimoto H; Dong L; Qian MG
Bioanalysis; 2020 Jul; 12(14):977-979. PubMed ID: 32686957
[No Abstract] [Full Text] [Related]
37. A high-speed liquid chromatography/tandem mass spectrometry platform using multiplexed multiple-injection chromatography controlled by single software and its application in discovery ADME screening.
Zhang J; Vath M; Ferraro C; Li Y; Murphy K; Zvyaga T; Weller H; Shou W
Rapid Commun Mass Spectrom; 2013 Apr; 27(7):731-7. PubMed ID: 23495019
[TBL] [Abstract][Full Text] [Related]
38. Strategies and analytical workflows to extend the dynamic range in quantitative LC-MS/MS analysis.
Ediage EN; Aerts T; Lubin A; Cuyckens F; Dillen L; Verhaeghe T
Bioanalysis; 2019 Jun; 11(12):1189-1206. PubMed ID: 31204858
[No Abstract] [Full Text] [Related]
39. Quantification below the LLOQ in regulated LC-MS/MS assays: a review of bioanalytical considerations and cautions.
Duggan JX
Bioanalysis; 2019 Apr; 11(8):797-814. PubMed ID: 30994002
[TBL] [Abstract][Full Text] [Related]
40. LC-MS bioanalysis of intact proteins and peptides.
Kang L; Weng N; Jian W
Biomed Chromatogr; 2020 Jan; 34(1):e4633. PubMed ID: 31257628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
